![Hong Ki Chae](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Ki Chae
Direktor/Vorstandsmitglied bei Da Information Co., Ltd.
Vermögen: 898 830 $ am 31.05.2024
Profil
Hong Ki Chae currently works at Da Information Co., Ltd., as Director from 2014 and Ettifos Co., as Director.
Mr. Chae also formerly worked at Dong-A Socio Holdings Co., Ltd., as Director, Senior Managing Director & Head-Finance, ST Pharm Co., Ltd., as Non-Executive Director, and DM Bio, Ltd.
(South Korea), as Director.
Mr. Chae received his graduate degree from Korea University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NEXTIN INC.
0,18% | 30.09.2023 | 18 913 ( 0,18% ) | 898 830 $ | 31.05.2024 |
Aktive Positionen von Hong Ki Chae
Unternehmen | Position | Beginn |
---|---|---|
Da Information Co., Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hong Ki Chae
Unternehmen | Position | Ende |
---|---|---|
Ettifos Co.
![]() Ettifos Co. Miscellaneous Commercial ServicesCommercial Services Ettifos Co. is an American company that specializes in developing a compact and low-cost on-board unit (OBU) that enables users to receive vehicle-to-everything (V2X) services on their smartphones. The private company is based in an undisclosed location, and the CEO of the company is Yong Je Lim. The OBU is available in Dedicated Short-Range Communications (DSRC) or Cellular Vehicle-to-Everything (C-V2X) technology. | Direktor/Vorstandsmitglied | - |
DM Bio, Ltd. (South Korea)
![]() DM Bio, Ltd. (South Korea) Pharmaceuticals: OtherHealth Technology DM Bio, Ltd. (KR) engages in the development and manufacture of pharmaceutical products. Its services include plant overview, cell culture, purification, fill and finish, and quality assurance. The company was founded in 2013 and is headquartered in Incheon, South Korea. | Direktor/Vorstandsmitglied | - |
ST PHARM CO.,LTD. | Direktor/Vorstandsmitglied | - |
DONG-A SOCIO HOLDINGS CO., LTD. | Finanzdirektor/CFO | - |
Ausbildung von Hong Ki Chae
Korea University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
DONG-A SOCIO HOLDINGS CO., LTD. | Health Technology |
ST PHARM CO.,LTD. | Health Technology |
Private Unternehmen | 3 |
---|---|
Da Information Co., Ltd. | |
DM Bio, Ltd. (South Korea)
![]() DM Bio, Ltd. (South Korea) Pharmaceuticals: OtherHealth Technology DM Bio, Ltd. (KR) engages in the development and manufacture of pharmaceutical products. Its services include plant overview, cell culture, purification, fill and finish, and quality assurance. The company was founded in 2013 and is headquartered in Incheon, South Korea. | Health Technology |
Ettifos Co.
![]() Ettifos Co. Miscellaneous Commercial ServicesCommercial Services Ettifos Co. is an American company that specializes in developing a compact and low-cost on-board unit (OBU) that enables users to receive vehicle-to-everything (V2X) services on their smartphones. The private company is based in an undisclosed location, and the CEO of the company is Yong Je Lim. The OBU is available in Dedicated Short-Range Communications (DSRC) or Cellular Vehicle-to-Everything (C-V2X) technology. | Commercial Services |